Manipal University Jaipur launches B.Pharm programme; admission open for 2026-27

Manipal University Jaipur (MUJ) has launched its Bachelor of Pharmacy (B.Pharm.) programme under the School of Pharmaceutical Sciences after receiving approval from the Pharmacy Council of India (PCI). The admissions for the inaugural 2026–27 academic sessions are open for the eligible applicants.

The introduction of the B.Pharm. programme marks an expansion of its professional education offering in the healthcare domain. The programme is designed to equip students with scientific knowledge, practical skills, research aptitude, and ethical values to meet the evolving necessities of the healthcare and pharmaceutical sectors.

The programme has been launched after the approval of the apex statutory body for pharmacy education in India. The course will include theoretical learning, laboratory training, industry exposure and research-oriented learning.

Also read Maharashtra’s pharmacy college boom going bust? Unchecked growth of pharma courses threat to livelihood

Advanced infrastructure to support learning

The School of Pharmaceutical Sciences at MUJ will provide students with access to the advanced labs, smart classrooms, seminar halls and modern research facilities and the University's vibrant academic ecosystem.

The programme will also continue to emphasize innovation, interdisciplinary learning, industry engagement and holistic student development. The elements are designed to promote the development of students' practical and research-based skills throughout the course.

Drawing on the Manipal group's legacy of more than 70 years in healthcare, education and research, the B.Pharm programme aims to prepare future-ready professionals for opportunities across the pharmaceutical and healthcare sectors.

Also read Pharmacy Council of India revamps B Pharma syllabus with AI, hospital training; rollout from 2026-27 session

Programme targets various career opportunities

Students will be prepared for careers in pharmaceutical manufacture, quality assurance, drug development, clinical research, hospital pharmacy, regulatory affairs, public health and healthcare innovation. The programme also aims to support opportunities in regulatory organisation, academic and entrepreneurship.

Speaking on the occasion, N. N. Sharma, President, Manipal University Jaipur, said, "The launch of the PCI-approved B.Pharm. The programme is another important step in strengthening our commitment to excellence in healthcare education. With the Manipal legacy, world-class infrastructure, experienced faculty, and a research-driven learning environment, we are confident that our students will emerge as competent professionals capable of making meaningful contributions to society and the healthcare ecosystem."